How Much Did Ennogen Raise?
Funding & Key Investors

Ennogen, an international pharmaceutical and medical device company, has secured $197M in total capital, with its most recent financing round bringing in $197M. This major strategic investment underscores the company's significant enterprise-level funding trajectory and its focus on addressing under-served clinical needs through the revitalization of heritage brands.

What is Ennogen?

Ennogen
ManufacturingPharmaceuticalsMedical Devices & Equipment

Ennogen Healthcare operates globally, specializing in therapeutic areas such as pain management, respiratory, and dermatology. The company's core mission involves improving patient communities' lives worldwide, coupled with a strong commitment to sustainability and community empowerment. Driven by an experienced management team, Ennogen is actively pursuing ambitious goals, including achieving Net Zero by 2040, positioning itself as a forward-thinking entity in the healthcare sector.

How much funding has Ennogen raised?

Ennogen has raised a total of $197M across 1 funding round:

2025

Debt

$197M

Debt (2025): $197M with participation from HSBC UK, Santander UK, and Barclays

Key Investors in Ennogen

HSBC UK

HSBC UK is a major financial institution providing a wide array of banking and financial services to individuals and businesses. Its involvement suggests a strong backing for Ennogen's significant funding needs, likely offering corporate banking and potential debt financing solutions.

Santander UK

Santander UK is a prominent bank offering comprehensive financial services, including access to finance for business expansion and international trade. Their participation indicates support for Ennogen's growth ambitions and global market penetration strategies.

Barclays

Barclays PLC is a multinational universal bank providing diverse financial services. Its investment in Ennogen highlights its role in supporting corporate and investment banking needs, potentially facilitating Ennogen's strategic financial maneuvers and operational scaling.

What's next for Ennogen?

The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Ennogen. This capital infusion is expected to fuel further expansion of its international operations, enhance its product development pipeline for heritage brands, and bolster its sustainability initiatives. Ennogen's strategic focus on under-served clinical needs, combined with its commitment to Net Zero by 2040, positions it for sustained impact and market leadership in the pharmaceutical and medical device industries.

See full Ennogen company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Boats & SubmarinesManufacturingAerospace & Defense
ManufacturingPharmaceuticals
ManufacturingMedical Devices & Equipment
Food & BeverageManufacturingRetailHospitalityRestaurant ReservationsGrocery Retail

Frequently Asked Questions Regarding Ennogen Financial Insights

What are the most recent funding rounds that Ennogen has completed, and what were the funding rounds?
Ennogen has recently completed 1 funding rounds: Debt on Jul 31, 2025.
What is the total amount of funding Ennogen has raised to date?
Ennogen has raised a total of $197M in funding to date.
How many funding rounds has Ennogen completed?
Ennogen has completed 1 funding rounds.
How much funding did Ennogen raise in its most recent funding round?
Ennogen raised $197M in its most recent funding round.
Who are the lead investors in Ennogen's latest funding round?
The lead investor in Ennogen's latest funding round was HSBC UK. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Ennogen's history?
The largest funding round in Ennogen's history was $197M.
See more information about Ennogen